Light Mode
$3.21 ↑ +0.00 (+0.00%) Trading Up from the previous close of $3.21, $0.05 below the day’s high of $3.26
-0.95 (-22.84%) / 6M
Momentum, market sentiment, and recent alerts
WHWK reads not so good: price sits below both the 20- and 200-day averages, the 12-month move is +32.6%.
No alerts for WHWK in the last day.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
Whitehawk Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It develops precision therapies for genetically-defined cancer patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes. The company was founded by Neil Desai in November 2007 and is headquartered in Morristown, NJ.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.